Status:
RECRUITING
Trigger Point Injection in Patients With Myofascial Pain Syndrome
Lead Sponsor:
Firat University
Conditions:
Injection Site
Fibromyalgia
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This study aims to compare the effectiveness of blinded versus ultrasound-guided trigger point injections into the trapezius muscle in patients with FMS. Seventy-five patients with FMS will participat...
Detailed Description
The primary objectives in treating Fibromyalgia Syndrome (FMS) are to deactivate trigger points, alleviate pain, and remove factors that exacerbate the condition. Recently, the use of ultrasound (US) ...
Eligibility Criteria
Inclusion
- Patients aged 20-60 years who met the 2013 ACR criteria
- Patients who will be diagnosed with FMS and cervical chronic MAS according to Travel and Simons' criteria
- Patients who had a palpated tense band in the upper trapezius muscle and at least 1 active trigger point
Exclusion
- Patients with a diagnosis of cervical radiculopathy, myelopathy, local or systemic infection, treatment for MAS in the last 3 months
- Patients who have symptom duration less than 3 months
- Patients with pregnancy status, acute or chronic disease that would cause clinical confusion at the time of the study
Key Trial Info
Start Date :
August 20 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 20 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06555523
Start Date
August 20 2024
End Date
September 20 2024
Last Update
August 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Songul
Elâzığ, Turkey (Türkiye), 23100